Changes in estrogen and progesterone receptor content of primary breast carcinoma during the menstrual cycle
- 1 December 1987
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 10 (3) , 273-278
- https://doi.org/10.1007/bf01805764
Abstract
This study was undertaken to determine if hormone receptor activity in breast cancers changes during different phases of the menstrual cycle. Estrogen (ER) and progesterone (PgR) receptors in seventy-eight primary breast carcinomas from premenopausal women were compared with the phase of the menstrual cycle at the time of biopsy. The frequency of ER positivity did not change, but PgR positivity became significantly higher after the early follicular phase. An increase in mean ER and PgR concentration was found (p<.05) in the late luteal phase. The results indicate that tumor ER and PgR values change during the menstrual cycle, probably in response to endogenous hormonal fluctuations, and this may account for some vicissitudes in establishing hormone dependence.This publication has 18 references indexed in Scilit:
- Variations in Estrogen and Progesterone Receptor Content in Premenopausal Breast Cancer Patients Throughout the Menstrual CycleTumori Journal, 1984
- Augmentation of progesterone receptor concentration by progesterone and estrogen treatments in the chick oviductJournal of Steroid Biochemistry, 1984
- Influence of Endogenous Hormone Levels on Tumor Estradiol and Progesterone ReceptorsPublished by Springer Nature ,1984
- Estradiol Receptor in Human Breast Cancers throughout the Menstrual CycleOncology, 1982
- Simultaneous measurement of estrogen and progesterone receptors in tumor cytosols with use of 125I-labeled estradiol and of 3H-R5020.Clinical Chemistry, 1981
- ESTROGEN-RECEPTORS AND BREAST-CANCER - PROGNOSTIC AND THERAPEUTIC IMPLICATIONS1980
- ESTROGEN AND PROGESTERONE RECEPTORS IN HUMAN-BREAST CANCER WITH CONCOMITANT ASSAY OF PLASMA 17-BETA-ESTRADIOL, PROGESTERONE, AND PROLACTIN LEVELS1979
- Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer.1977
- Control of Uterine Estrogen Receptor Levels by ProgesteroneEndocrinology, 1976
- Predicting Response to Endocrine Therapy in Human Breast Cancer: A HypothesisScience, 1975